Pan-cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment

被引：8
|
作者：
Jiang, Tao [1 ,2 ,3 ]
Jia, Qingzhu [4 ]
Fang, Wenfeng [5 ]
Ren, Shengxiang [1 ,2 ]
Chen, Xiaoxia [1 ,2 ]
Su, Chunxia [1 ,2 ]
Zhang, Li [5 ]
Zhou, Caicun [1 ,2 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Thorac Canc Inst, Dept Med Oncol, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Resp Res Inst, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China
[4] Third Mil Med Univ, Inst Canc, Xinqiao Hosp, Chongqing, Peoples R China
[5] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China
来源：
CLINICAL AND TRANSLATIONAL MEDICINE | 2020年 / 10卷 / 02期
基金：
中国国家自然科学基金;
关键词：
biomarker; immune checkpoint inhibitors; immune microenvironment; TERT;
D O I：
10.1002/ctm2.109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome
    Chen, Xiao-Juan
    Ren, Aiqun
    Zheng, Liang
    Zheng, En-Dian
    Jiang, Tao
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors
    Chen, Yi-Chao
    Zheng, Wei-Zhong
    Liu, Chun-Peng
    Zhao, Yong-Qiang
    Li, Jun-Wei
    Du, Ze-Sen
    Zhai, Tian-Tian
    Lin, Hao-Yu
    Shi, Wen-Qi
    Cai, Shan-Qing
    Pan, Feng
    Qiu, Si-Qi
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [3] MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
    Zhou, Yong
    Tan, Yuan
    Zhang, Qin
    Duan, Qianqian
    Chen, Jun
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [4] MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
    Yong Zhou
    Yuan Tan
    Qin Zhang
    Qianqian Duan
    Jun Chen
    European Journal of Medical Research, 27
  • [5] THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
    Lin, Yufeng
    Xie, Mingxu
    Lau, Harry C.
    Wang, Luyao
    Li, Qing
    Chen, Danyu
    Jiang, Lanping
    Yu, Jun
    GASTROENTEROLOGY, 2024, 166 (05) : S171 - S171
  • [6] Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
    Bai, Rilan
    Lv, Zheng
    Xu, Dongsheng
    Cui, Jiuwei
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [7] Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
    Rilan Bai
    Zheng Lv
    Dongsheng Xu
    Jiuwei Cui
    Biomarker Research, 8
  • [8] A pan-cancer analysis of MUC family genes as potential biomarkers for immune checkpoint therapy.
    Li, Yang
    Duan, Qianqian
    Tan, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy
    Zhu, Yan
    Yan, Chun
    Wang, Xiaofei
    Xu, Zhijian
    Lv, Jianjian
    Xu, Xiaomei
    Yu, Wenjun
    Zhou, Mi
    Yue, Lu
    CANCER BIOLOGY & THERAPY, 2022, 23 (01) : 104 - 111
  • [10] Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer
    Sivapiragasam, Abirami
    Kumar, Prashanth Ashok
    Sokol, Ethan S.
    Albacker, Lee A.
    Killian, Jonathan K.
    Ramkissoon, Shakti H.
    Huang, Richard S. P.
    Severson, Eric A.
    Brown, Charlotte A.
    Danziger, Natalie
    McGregor, Kimberly
    Ross, Jeffrey S.
    CANCER MEDICINE, 2021, 10 (01): : 53 - 61
12345